Ophthalmoparesis as an unusual manifestation of anti-3‑hydroxy-3-methyl-glutaryl-coenzyme A reductase antibody-associated myopathies
Neuromuscular Disorders · 2024-09 · 42 · 1-4
DOI: 10.1016/j.nmd.2024.06.005 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuromuscular Disorders, 2024-09. Verfasst von Brendan Putko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic-Rochester, Rochester, MN, USA. Hauptthemen laut MEDLINE: Ophthalmoplegia, Hydroxymethylglutaryl CoA Reductases, Autoantibodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
We describe two anti-3‑hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR) antibody-positive patients with treatment-responsive ophthalmoparesis. Patient 1 was a 53-year-old male with progressive proximal limb weakness, dysphagia, ptosis, and diplopia over 6 weeks and creatine kinase (CK) of 3,512 units/L. Patient 2 was a 55-year-old female with progressive proximal weakness, dysarthria, ptosis, diplopia, and dyspnea over 2 weeks with CK of 31,998 units/L. Both patients had normal thyroid studies and repetitive nerve stimulation, myopathic electromyography with fibrillation potentials, magnetic resonance imaging demonstrating abnormal enhancement of extraocular muscles, muscle biopsy showing necrotic myofibers, and positive anti-HMGCR antibodies. Patient 1 also had weakly positive anti-PM/Scl antibodies. Immunomodulatory therapies led to resolution of oculobulbar weakness and normalization of CK levels in both patients, while limb weakness resolved completely in patient 1 and partially in patient 2. These cases expand the phenotypic spectrum of anti-HMGCR antibody-associated myopathies to include subacute ophthalmoparesis with limb-girdle weakness and markedly elevated CK.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic-Rochester, Rochester, MN, USA.
- Department of Neurology, Washington University, St. Louis, Missouri, USA.
- Department of Ophthalmology and Visual Sciences, Washington University, St. Louis, Missouri, USA.
- Division of Neurology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
- Division of Neurology, Department of Medicine, University of Alberta, Edmonton, AB, Canada. Electronic address: beecher@ualberta.ca.
- Department of Neurology, Mayo Clinic-Rochester, Rochester, MN, USA. Electronic address: liewluck.teerin@mayo.edu.
Zitieren
APA
Putko, B., Pestronk, A., Van Stavern, G. P., Phan, C. L., Beecher, G., & Liewluck, T. (2024). Ophthalmoparesis as an unusual manifestation of anti-3‑hydroxy-3-methyl-glutaryl-coenzyme A reductase antibody-associated myopathies. Neuromuscular Disorders, 42, 1-4. https://doi.org/10.1016/j.nmd.2024.06.005
Vancouver
Putko B, Pestronk A, Van Stavern GP, Phan CL, Beecher G, Liewluck T. Ophthalmoparesis as an unusual manifestation of anti-3‑hydroxy-3-methyl-glutaryl-coenzyme A reductase antibody-associated myopathies. Neuromuscular Disorders. 2024;42:1-4. doi:10.1016/j.nmd.2024.06.005
BibTeX
@article{Putko2024,
author = {Putko, Brendan and Pestronk, Alan and Van Stavern, Gregory P and Phan, Cecile L and Beecher, Grayson and Liewluck, Teerin},
title = {Ophthalmoparesis as an unusual manifestation of anti-3‑hydroxy-3-methyl-glutaryl-coenzyme A reductase antibody-associated myopathies},
journal = {Neuromuscular Disorders},
year = {2024},
volume = {42},
pages = {1--4},
doi = {10.1016/j.nmd.2024.06.005}
}
EUVIMED